Addition of gemtuzumab ozogamicin to induction chemotherapy in adult patients with acute myeloid leukaemia: a meta-analysis of individual patient data from randomised controlled trials.
- Submitting institution
-
University of Oxford
- Unit of assessment
- 2 - Public Health, Health Services and Primary Care
- Output identifier
- 6204
- Type
- D - Journal article
- DOI
-
10.1016/s1470-2045(14)70281-5
- Title of journal
- The Lancet. Oncology
- Article number
- 9
- First page
- 986
- Volume
- 15
- Issue
- 9
- ISSN
- 1470-2045
- Open access status
- Out of scope for open access requirements
- Month of publication
- August
- Year of publication
- 2014
- URL
-
-
- Supplementary information
-
https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045%2814%2970281-5/fulltext#supplementaryMaterial
- Request cross-referral to
- -
- Output has been delayed by COVID-19
- No
- COVID-19 affected output statement
- -
- Forensic science
- No
- Criminology
- No
- Interdisciplinary
- No
- Number of additional authors
-
14
- Research group(s)
-
-
- Citation count
- 313
- Proposed double-weighted
- No
- Reserve for an output with double weighting
- No
- Additional information
- -
- Author contribution statement
- -
- Non-English
- No
- English abstract
- -
